"Loophole" Tightens Around Double Patenting

Dan Whalen is a JD Candidate at Osgoode Hall Law School Bayer was dealt a blow when the Federal Court of Appeal upheld the decision to deny the company a patent of a medical compound because it held a product-by-process patent for the substance already. In 1987, when the pharmaceutical giant received said rights, the […]